Mike Radossich has been named the president of the Solvay Group’s Novecare global business unit. He will succeed Emmanuel Butstraen, who will leave to pursue opportunities outside of the Group. Radossich will lead the business unit, which makes specialty surfactants and formulations serving customers in agriculture, coatings, home, and personal care, industrial and oil and gas markets. He will be based in Novecare’s headquarters in Princeton, N.J., U.S.A.
Radossich came to Solvay from Cytec Industries when the group acquired its businesses in 2016. He has more than 25 years of experience in managing global and regional teams in commercial, operational and technical functions. He most recently headed up the Group’s Technology Solutions global business unit. Radossich earned his undergraduate degree in Chemical Engineering from Villanova University and an MBA from Fairleigh Dickinson University.
Meanwhile, Chen Pu will succeed Radossich as president of the Technology Solutions global business unit, which is comprised of the legacy Cytec Mining Solutions, Additive Technologies and Phosphorus Specialties businesses acquired in 2016. He will be based in the Technology Solutions’ headquarters in Saddle Brook, N.J., U.S.A.
Chen is a 24-year Solvay veteran who most recently headed the Group’s Oil & Gas business as an executive vice president. His background includes commercial, technical, operational and research roles in advanced formulations and related applications for industrial, energy and coatings customers, among others. In addition to leading global market divisions, he also served as head of Solvay Novecare’s two largest regions in the Asia Pacific and North America. Chen holds a doctorate in Organic Chemistry from the National University of Singapore and an MBA from the University of Surrey in Guilford, UK.
Solvay is an advanced materials and specialty chemicals company, headquartered in Brussels, Belgium, with around 26,800 employees in 61 countries. Net sales were EUR 10.1 billion (USD 11.87 billion) in 2017, with 90% from activities where Solvay ranks among the world’s top 3 leaders, resulting in an EBITDA margin of 22%. Solvay SA (SOLB.BE) is listed on Euronext Brussels and Paris (Bloomberg: SOLB.BB – Reuters: SOLB.BR) and in the United States its shares (SOLVY) are traded through a level-1 ADR program.